No increase in risk for breast cancer seen for BRCA carriers following predominantly surgical menopause. HealthDay News — Use ...
Researchers determined the predictive value of the Geriatric 8 Screening tool for OS and PFS in older patients with ...
The investigational cortisol modulator relacorilant plus nab-paclitaxel improved survival in platinum-resistant ovarian ...
Study results are based on Surveillance, Epidemiology, and End Results-Medicare data for 166,581 patients receiving surgery or radiation for localized prostate cancer.
Drs Dean Ornish and Peter Carroll presented their research on the effects of an intensive lifestyle program on outcomes for patients with prostate cancer.
In this phase 2 study, researchers aimed to determine whether adding elraglusib to gemcitabine and nab-paclitaxel improved survival in patients with treatment-naïve metastatic PDAC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results